1.تاج الدین, ب. رمدانی، ن.(۱۳۹۳)، «نانو، فنّاوری نوین در بستهبندی - معایب و مزیتها»، بیست و دومین کنگره ملّی علوم و صنایع غذایی، گرگان، دانشگاه علوم کشاورزی و منابع طبیعی گرگان، دسترس در:
2. سازمان غذا و دارو ایران، (آبان ماه 1394)، «چک لیست ارزیابی پرونده مواد اولیه ظروف بستهبندی مواد غذایی بر پایه فنّاوری نانو قابل دسترس در» :
3. EPA; nanoparticle , available at :http://epa.gov/ncer/nano/questions/index.html
4. Scientific Basis for the Definition of the Term “Nanomaterial”, 6 July 2010 , available at :
5. Europen commission, )2009(, “Guideline on the readability of the labelling and package leaflet of medicinal products for human use,” Amendment of Directive 2001/83/EC by Directive 2004/27/EC.
6. European commission, (2015), “Guideline on the packaging information of medical product for human use aphorized”, by the union Directive 2012/26/EU1 and Regulation (EC) No726/2004 as amended for the last time by Regulation (EU) No 1027/20122).
7. Commission Regulation (EU) No. 10/2011 of 14 of January (2011). “on Plastic Materials and Articles Intended to Come in Contact with Food”. Official Journal of the European Union.
8. EMEA,(European Medicines Evaluation Agency)-London, 19 May 2005. EMEA/CVMP/205/04.
10. FDA, (June 2014), “draft guidance for industry considering whether an FDA regulated product involves the application of nanotechnology available”. at:https://www.fda.gov/downloads/regulatoryinformation/guidances/ucm401695.pdf .
11. Mark n duvall, (2012). “FDA Regulation of nanotechnology,”.
13. FDA- Guidance for Industry Safety of Nanomaterials in Cosmetic Products June (2014).
14. WHO, (2002). “Annex 9– WHO Technical Report Series ,”. No. 902.
15. REACH- RNC/RIP-oN2/FPR/1/Final 01 July 2011.
16. TGA (May 2011). “labelling and packaging regulatory framework ,” https://www.tga.gov.au/tga-labelling-and-packaging-regulatory-framework.
)
